A notification by CDSCO confirms that the applications for manufacturing COVID-19 diagnostic kits were still being processed.
A notification released by the Central Drugs Standards Control Organisation (CDSCO) on 19 March 2020 states that manufacturing or importing of test kits were still being evaluated and that it would be processed on high priority.
News by Economic times on 24 March 2020 states that Co-Diagnostics has received a license to manufacture test kits for validation and not for selling them in the Indian market. Further, it states that CDSCO has been issuing a licence to companies to get their Covid-19 testing kits validated by the National Institute of Virology.
Thus we conclude that Co-Diagnostics had received a licence for test kit validation and not for manufacturing the kit. The other part of the claim which states that the American biotech, Co-Diagnostics had developed testing kit in one week and had zero track record which sold only $700 worth of tests in 2018 cannot be verified as there is currently insufficient information.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.